SLC39A10 and cancer: The discovery of the role of the ZIP6/ZIP10 heteromer in triggering mitosis has enabled us to use ZIP6 or ZIP10 blocking antibodies to prevent mitosis, an important discovery to help target cell division in diseases of aberrant proliferation, including cancer.